GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GRAIL Inc (NAS:GRAL) » Definitions » Current Deferred Revenue

GRAIL (GRAL) Current Deferred Revenue : $0.0 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is GRAIL Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

GRAIL's current deferred revenue for the quarter that ended in Dec. 2024 was $0.0 Mil.

GRAIL Current Deferred Revenue Historical Data

The historical data trend for GRAIL's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GRAIL Current Deferred Revenue Chart

GRAIL Annual Data
Trend Dec18 Dec19 Dec22 Dec23 Dec24
Current Deferred Revenue
- - - - -

GRAIL Quarterly Data
Dec18 Dec19 Jun20 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

GRAIL Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of GRAIL's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

GRAIL Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GRAIL Inc (NAS:GRAL) » Definitions » Current Deferred Revenue
Comparable Companies
CDNA MYGN OPK NEO CSTL FLGT PSNL ATLN STIM ACRS TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD WAT NTRA
Traded in Other Exchanges
NL0:Germany
Address
1525 O’Brien Drive, Menlo Park, CA, USA, 94025
Website
https://www.grail.com
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.